Progress, Potential, and Possibilities Podcast / Show

Dr. Marc Hedrick, MD - CEO, Plus Therapeutics - Radiotherapeutics For Difficult-To-Treat CNS Cancers

Dec 2, 2025
Ask episode
Chapters
Transcript
Episode notes